Bensang Pharmaceuticals Officially Enters Japanese Duty-Free Market, Opening a New Chapter in Health Consumption

TOKYO, JAPAN – Media OutReach Newswire – 3 June 2025 – Bensang Pharmaceuticals (China), a leading health and wellness brand, announced today that its full product line has officially entered Tokyo duty-free stores, marking a deep collaboration in the health consumption sector. This partnership not only provides consumers with a global authentic purchasing channel but also integrates high-quality health products with the premium duty-free shopping experience.

Powerful Collaboration to Create a New Duty-Free Health Consumption Scene

Tokyo Duty Free is a world-leading travel retail platform with a global supply chain network and millions of passenger flows, serving as a key gateway for premium brands entering international markets. Bensang Pharmaceuticals, with its scientific formulations, stringent quality control, and diverse product portfolio, has earned strong market recognition. The brand will set up exclusive display zones in duty-free stores and launch limited-time promotional offers to meet the diverse health product demands of both international travelers and local consumers.

With growing health awareness, wellness products have become a new growth driver in duty-free consumption. Bensang’s commitment to R&D and product innovation aligns perfectly with Tokyo Duty Free’s positioning as the “preferred destination for quality living.”

Strategic Expansion to Capture the Health Consumption Boom

As China’s health industry continues to expand, its market size is projected to exceed ¥20 trillion by 2025. Duty-free channels, with their “authenticity guarantee + competitive pricing,” have become the top choice for high-net-worth individuals and cross-border shoppers. Bensang’s entry into duty-free stores is a crucial step in its globalization strategy, driving the Chinese health supplement industry toward premium and international development.

http://www.bensangzy.com/

Hashtag: #BensangPharmaceuticals

The issuer is solely responsible for the content of this announcement.